Although the treatment of malignant tumors has entered an era of comprehensive therapy integrating chemotherapy, targeted therapy, immunotherapy, and other modalities, there is still a significant gap from individualized precise treatment. The development of in vivo and in vitro drug sensitivity testing models has promoted the advances in functional precision medicine. Among these models, high-throughput microfluidic platforms offer distinct advantages for in vitro drug sensitivity testing due to their features of high throughput, high sensitivity, high integration, and miniaturization, thereby enabling precise manipulation of microliter-volume fluid flow and reactions and simulating the liquid microenvironment of tumor growth. This article reviews the recent research advances in the application of high-throughput microfluidic platforms in the precise diagnosis and treatment of tumors, in order to provide a reference for the individualized treatment of malignant tumors.